IRTC (iRhythm Holdings) Current Deferred Revenue: $4.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRTC iRhythm Holdings Inc IRTC
71 GF Score
Price $112.28
GF Value $164.43
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is iRhythm Holdings Current Deferred Revenue?

iRhythm Holdings IRTC +1.26% 71 Current Deferred Revenue is $4.1 Mil as of Mar. 2026. GuruFocus rates IRTC with a GF Score™ of 71/100 and a GF Value™ of $164.43 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

iRhythm Holdings's current deferred revenue for the quarter that ended in Mar. 2026 was $4.1 Mil.

iRhythm Holdings Current Deferred Revenue Related Terms

iRhythm Holdings Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for iRhythm Holdings's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRhythm Holdings Current Deferred Revenue Chart

iRhythm Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.05 3.05 3.31 2.93 4.20

iRhythm Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 3.50 4.22 4.20 4.06
IRTC
71GF Score
iRhythm Holdings Inc IRTC
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $4.1 Mil mean?
iRhythm Holdings (IRTC) has a Current Deferred Revenue of $4.1 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on iRhythm Holdings and its competitors.
Is iRhythm Holdings' Current Deferred Revenue too high?
iRhythm Holdings' current Current Deferred Revenue is $4.1 Mil. Overall, iRhythm Holdings has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Current Deferred Revenue compare to HAE and LIVN?
iRhythm Holdings' Current Deferred Revenue of $4.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Devices & Instruments company?
A good Current Deferred Revenue depends on the Medical Devices & Instruments industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on iRhythm Holdings and its competitors. iRhythm Holdings's current Current Deferred Revenue is $4.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Significantly Undervalued. The stock's GF Value™ is $164.43, compared to a current price of $112.28 — trading 31.7% below its estimated fair value. The current Current Deferred Revenue is $4.1 Mil. iRhythm Holdings' overall GF Score™ is 71/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Current Deferred Revenue is $4.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRhythm Holdings (IRTC) Overvalued in 2026?

Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued. The current stock price of $112.28 is trading 31.7% below its estimated GF Value™ of $164.43. GuruFocus considers iRhythm Holdings to be Significantly Undervalued.

Key valuation signals for IRTC:

  • Current Deferred Revenue: $4.1 Mil
  • GF Value™: $164.43 vs. price of $112.28 (31.7% below fair value)
  • GF Score™: 71/100 with 1 warning sign

No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRhythm Holdings Business Description

Other Exchanges 0A7L:UK
Address 699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
71GF Score

Get the complete analysis for IRTC

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$112.28
Price
$164.43
GF Value